Psychiatric research: psychoproteomics, degradomics and systems biology (Q37157851)

18 August 2017

1 reference

title

Psychiatric research: psychoproteomics, degradomics and systems biology (English)

1 reference

18 August 2017

1 reference

Firas H Kobeissy

1

0 references

Kevin K W Wang

object named as

Kevin K W Wang

5

0 references

author name string

Shankar Sadasivan

2

1 reference

18 August 2017

Jing Liu

3

1 reference

18 August 2017

Mark S Gold

4

1 reference

18 August 2017

publication date

1 April 2008

1 reference

Expert Review of Proteomics

18 August 2017

published in

1 reference

18 August 2017

volume

5

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

293-314

1 reference

Proteomics in neurosciences

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Proteomics in postgenomic neuroscience: the end of the beginning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Neuroproteomics: expression profiling of the brain's proteomes in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Recent advances in neuroproteomics and potential application to studies of drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Proteomic identification of biomarkers of traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Proteomic analysis in the neurosciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Distinct proteomic profiles of amphetamine self-administration transitional states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Application of proteomics technology to the field of neurotrauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Neurexins: three genes and 1001 products

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

[Proteomics: biomarker research in psychiatry]

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

A striking organization of a large family of human neural cadherin-like cell adhesion genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

The human plasma proteome: history, character, and diagnostic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

How proteomics reveals potential biomarkers in brain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Enhanced resolution of glycosylphosphatidylinositol-anchored and transmembrane proteins from the lipid-rich myelin membrane by two-dimensional gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Cocaine dependence: a disease of the brain's reward centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Neurobiology of addiction: treatment and public policy ramifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

The neuroscience of addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Dopamine in drug abuse and addiction: results from imaging studies and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Drug dependence and addiction, III: Expectation and brain function in drug abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Molecular genetics of addiction vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Addiction molecular genetics: 639,401 SNP whole genome association identifies many "cell adhesion" genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

The expanding role of PSD-95: a new link to addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Under siege: The brain on opiates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Proteomics: quantitative and physical mapping of cellular proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Molecular mechanisms of opiate and cocaine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Molecular basis of opioid dependence: role of signal regulation by G-proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Opioids: cellular mechanisms of tolerance and physical dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

New approaches to study the development of morphine tolerance and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Spinal PKC activity and expression: role in tolerance produced by continuous spinal morphine infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Effect of long-term exposure of SH-SY5Y cells to morphine: a whole cell proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Proteomic analysis of rat prefrontal cortex in three phases of morphine-induced conditioned place preference

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Morphinome--proteome of the nervous system after morphine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Rat brain proteome in morphine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Intermittent administration of morphine alters protein expression in rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Effect of chronic morphine exposure on the synaptic plasma-membrane subproteome of rats: a quantitative protein profiling study based on isotope-coded affinity tags and liquid chromatography/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Concurrent calpain and caspase-3 mediated proteolysis of alpha II-spectrin and tau in rat brain after methamphetamine exposure: a similar profile to traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Ecstasy toxicity: a comparison to methamphetamine and traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Calpain and caspase proteolytic markers co-localize with rat cortical neurons after exposure to methamphetamine and MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

CREB-binding protein controls response to cocaine by acetylating histones at the fosB promoter in the mouse striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Protein expression profile in the striatum of acute methamphetamine-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Protein expression profile in the striatum of rats with methamphetamine-induced behavioral sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Methamphetamine causes alterations in the MAP kinase-related pathways in the brains of mice that display increased aggressiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Novel differential neuroproteomics analysis of traumatic brain injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Differential protein expression in the corpus callosum (splenium) of human alcoholics: a proteomics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Proteome analysis of the dorsolateral prefrontal region from healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Cerebellar vermis proteome of chronic alcoholic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Differential protein expression in the prefrontal white matter of human alcoholics: a proteomics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Differential protein expression profiles in the hippocampus of human alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

CNS proteomes in alcohol and drug abuse and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Epidemiology of nonaffective acute remitting psychosis vs schizophrenia. Sex and sociocultural setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Schizophrenia proteomics: biomarkers on the path to laboratory medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Schizophrenia: diverse approaches to a complex disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

The synaptic hypothesis of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Neuropathology of schizophrenia: a mini review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Functional genomics and schizophrenia: endophenotypes and mutant models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Schizophrenia: a common disease caused by multiple rare alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Genomic approaches to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Genetics of schizophrenia and bipolar affective disorder: strategies to identify candidate genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

CSF biomarker discovery using label-free nano-LC-MS based proteomic profiling: technical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Altered proteins of the anterior cingulate cortex white matter proteome in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Impairment in basal limbic function in schizophrenia during affect recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Anterior cingulate pathology and social cognition in schizophrenia: a study of gray matter, white matter and sulcal morphometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Neurogenesis and major depression: implications from proteomic analyses of hippocampal proteins in a rat depression model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

The stress system in the human brain in depression and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Neuropsychological performance in patients with depression is associated with clinical, etiological and genetic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Gamma oscillations and spontaneous network activity in the hippocampus are highly sensitive to decreases in pO2 and concomitant changes in mitochondrial redox state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Stress sensitivity and resilience in the chronic mild stress rat model of depression; an in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Neuronal plasticity and survival in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Human cerebrospinal fluid peptidomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Proteomics analysis of prefractionated human lumbar cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

CSF metabolic and proteomic profiles in patients prodromal for psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Low cerebrospinal fluid glutamate and glycine in refractory affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Rapid discovery of putative protein biomarkers of traumatic brain injury by SDS-PAGE-capillary liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Anion and cation mixed-bed ion exchange for enhanced multidimensional separations of peptides and phosphopeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

High-coverage quantitative proteomics using amine-specific isotopic labeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Quantitative proteomics of mouse brain and specific protein-interaction studies using stable isotope labeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Identification of protein vaccine candidates from Helicobacter pylori using a preparative two-dimensional electrophoretic procedure and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Nitroproteins from a human pituitary adenoma tissue discovered with a nitrotyrosine affinity column and tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Oxidative stress in the aging murine olfactory bulb: redox proteomics and cellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: Mitochondrial dysfunction, glutamate dysregulation and impaired protein synthe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Proteomic identification of nitrated proteins in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Protease degradomics: a new challenge for proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Identification of caspase-3 degradome by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Discovery and development of biomarkers of neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Metabolomics: current technologies and future trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Chemical diagnosis of Lesch-Nyhan syndrome using gas chromatography-mass spectrometry detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Metabolomics and systems biology: making sense of the soup

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

The evolution of molecular biology into systems biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Protection of endogenous enkephalin catabolism as natural approach to novel analgesic and antidepressant drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Nociceptin/orphanin FQ metabolism and bioactive metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Aminophosphinic inhibitors as transition state analogues of enkephalin-degrading enzymes: a class of central analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Methamphetamine enhances the cleavage of the cytoskeletal protein tau in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Proteomic analysis identifies alterations in cellular morphology and cell death pathways in mouse brain after chronic corticosterone treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Computational systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Systems biology: a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Emergence of Scaling in Random Networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Systems biology in neuroscience: bridging genes to cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Mass spectrometry-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

K+ channel regulation of signal propagation in dendrites of hippocampal pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Integrated genomic and proteomic analyses of a systematically perturbed metabolic network

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

The role of analytical sciences in medical systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Getting to synaptic complexes through systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Systems biology and combination therapy in the quest for clinical efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

The NMDA antagonist model for schizophrenia: promise and pitfalls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Antagonists of the NMDA receptor-channel complex and motor coordination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Molecular biological investigations into the role of the NMDA receptor in the pathophysiology of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Systems biology approaches for toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Dysfunction of ventral striatal reward prediction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Increased dopamine transmission in schizophrenia: relationship to illness phases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

The neurochemical circuitry of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Calpain- and caspase-mediated alphaII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

In-vivo topography of structural alterations of the anterior cingulate in patients with schizophrenia: New findings and comparison with the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Functional and quantitative proteomics using SILAC

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

A Multidimensional Differential Proteomic Platform Using Dual-Phase Ion-Exchange Chromatography−Polyacrylamide Gel Electrophoresis/Reversed-Phase Liquid Chromatography Tandem Mass Spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Identification and preliminary validation of novel biomarkers of acute hepatic ischaemia/reperfusion injury using dual-platform proteomic/degradomic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Elevation of cytoskeletal protein breakdown in aged Wistar rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.2.293

21 January 2018

Identifiers

DOI

10.1586/14789450.5.2.293

1 reference

18 August 2017

1 reference